ПРОТИВОРЕЦИДИВНАЯ ТЕРАПИЯ БОЛЕЗНИ КРОНА В ПОСЛЕОПЕРАЦИОННОМ ПЕРИОДЕ (обзор литературы)

болезнь Крона, рецидив, терапия

1. Воробьев, Г.И. Неспецифические воспалительные заболевания кишечника / Г.И.Воробьев, И.Л.Халиф // М.: Миклош, 2008. - с. 248-251.

2. Головенко, А.О. Профилактика послеоперационных рецидивов болезни Крона. / A.О.Головенко, И.Л.Халиф, О.В.Головенко и соавт. // Колопроктология. - 2012. - 4 (42). - с. 40-48.

3. Голышева, С.В. Качество жизни больных неспецифическим язвенным колитом и болезнью Крона до и после операции. / С.В.Голышева // Автореферат дис.. канд. мед. наук. - Москва: Первый МГМУ им. Сеченова, 2007. - с. 24.

4. Репетий, Н.Г. Язвенный колит и болезнь Крона: о выборе решения к переходу от консервативного лечения к хирургическому / Н.Г.Репетий, B.Б.Александров, О.Ю.Рахимова // Медицинский Вестник МВД. - 2010. - 4 (47). - с. 12-15.

5. Agrez, M.V. et al. Surgical history of Crohn’s disease in a well-defined population. / M.V.Agrez. // Mayo Clin Proc. - 1982. - 57 (12). - р. 747-752.

6. Aguas, M. Adalimumab in prevention of postoperative recurrence of Crohn’s disease in high-risk patients. / M.Aguas, G.Bastida, E.Cerrillo, et al. // World J. Gastroenterol. - 2012. - 18 (32). - р. 43914398.

7. Araki, T. The impact of postoperative infliximab maintenance therapy on preventing the surgical recurrence of Crohn’s disease: a single-center paired case-control study. / T.Araki, K.Uchida, Y.Okita, et al. // Surg. Today. - 2014. - 44 (2). - р. 291-296.

8. Ardizzone, S. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn’s disease. / S.Ardizzone, G.Maconi, G.M.Sampietro et al. // Gastroenterology. - 2004. -127. - р. 730-740.

9. Armuzzi, A. Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn’s disease: an open-label pilot study. / M.Regueiro, K.E.Kip, L.Baidoo et al. // J. Crohns Colitis. - 2013. -7 (12). - р. 623-629.

10. Bernell, O. Risk factors for surgery and postoperative recurrence in Crohn’s disease. / O.Bernell, A.Lapidus, G.Hellers. // Ann. Surg. -2000. - 231. - р. 38-45.

11. Bernell, O. Risk factors for surgery and recurrence in 907 patients with primary ileocaecalCrohn’s disease. / O.Bernell, A.Lapidus, G.Hellers // Br. J. Surg. - 2000. - 87 (12). - р. 1697-701.

12. D’Haens, GR. Early lesions of recurrent Crohn’s disease caused by infusion of intestinal contents in excluded ileum. / G.R.D’Haens, K.Geboes, M.Peeters et al. // Gastroenterology. - 1998. - 114. - p. 262-267.

13. De Cruz, P. Crohn’s disease management after intestinal resection: a randomised trial. / P.De Cruz, M.A.Kamm, A.L.Hamilton et al. // Lancet. - 2015. -385 (9976). - Р. 1406-1417.

14. Doherty, G. Interventions for prevention of postoperative recurrence of Crohn’s disease. / G.Doherty, G.Bennett, S.Patil et al. // Cochrane Database Syst Rev. - 2009: - 10.1002/14651858.CD006873.pub2.

15. Ewe, K. Postoperative recurrence of Crohn’s disease in relation to radicality of operation and sulfasalazine prophylaxis: a multicenter trial. / K.Ewe, C.Herfarth, H.Malchow et al. // Digestion. - 1989. - 42. - p. 224-232.

16. Ford, A.C. 5-aminosalicylates prevent relapse of Crohn’s disease after surgically induced remission: systematic review and meta-analysis. / A.C.Ford, K.J.Khan, N.J.Talley et al. // Am. J. Gastroenterol. - 2011. - 106 (3). - p. 413-420.

17. Greenstein, A.J. Perforating and nonperforating indications for repeated operations in Crohn’s disease: evidence for two clinical forms. / A.J.Greenstein et al. // Gut. - 1988. - 29 (5). - p. 588-592.

18. Hanauer, S.B. Postoperative maintenance of Crohn’s disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. / S.B.Hanauer, B.I.Korelitz, P.Rutgeerts et al. // Gastroenterology. -2004. - 127. - p. 723-729.

19. Harvey, R.F. A simple index of Crohn’s-disease activity. / R.F.Harvey, J.M.Bradshaw. // Lancet. -1980. - 1 (8167). - p. 514.

20. Hashash, J.G. A Practical Approach to Preventing Postoperative Recurrence in Crohn’s Disease. /J.G.Hashash, M.Regueiro. // Curr. Gastroenterol. Rep. - 2016. - May. - 18 (5). - p. 25.

21. Hashash, J.G. The evolving management of postoperative Crohn’s disease. / J.G.Hashash, M.D.Regueiro // Expert Rev. Gastroenterol. Hepatol. - 2012. - 6 (5). - p. 637-48.

22. Hellers, G. Crohn’s disease in Stockholm county 1955-1974. A study of epidemiology, results of surgical treatment and long-term prognosis. / G.Hellers // Acta. Chir. Scand. Int. J. Colorectal Disease. - 2007. -22 (9). - p. 1043-1049.

23. Herfarth, H.H. Inflamm Bowel. / H.H.Herfarth, A.J.Katz, S.B.Hanauer et al.// Dis. - 2013. - 19 (5). -p. 1073-1079.

24. Hofer, B. The impact of clinical types of disease manifestation on the risk of early postoperative recurrence in Crohn’s disease. / B.Hofer et al. // Hepatogastroenterology. - 2001. - 48 (37). - p. 152155.

25. Jason, M. Swoger and Miguel Regueiro Preventive therapy in postoperative Crohn’sdisease. / M. Jason. // Current Opinion in Gastroenterology. - 2010. - 26. - p. 337-343.

26. Kane, S.V. Tobacco use is associated with accelerated clinical recurrence of Crohn’s disease after surgically induced remission. / S.V.Kane, M.Flicker, F.Katz-Nelson // J. Clin. Gastroenterol. - 2005. -39 (1). - p. 32-35.

27. Latella, G. Results of the 4th scientific workshop of the ECCO (I): pathophysiology of intestinal fibrosis in IBD. / G.Latella, G.Rogler, G.Bamias et al. // J. Crohns Colitis. - 2014. - pii: S1873-9946 (14) 00120-S1873-9946(14) 00122.

28. McLeod, R.S. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn’s disease. / R.S.McLeod, B.G.Wolff, A.H.Steinhart et al. // Gastroenterology. - 1995. - 109. - p. 404-413.

29. Michelassi, F. Primary and recurrent Crohn’s disease. Experience with 1379 patients. / F.Michelassi, T.Balestracci, R.Chappel et al. // Ann. Surg. - 1991. -214. - p. 230-238.

30. Modigliani, R. Clinical, biological and endoscopy picture of attacks of Crohn’s disease. Evolution on prednisolone. / R.Modigliani, J.Mary, J.Simon // Gastroenterology. - 1990. - 98. - p. 811-818.

31. Ng, S.C. Management of postoperative Crohn’s disease. / S.C.Ng, M.A.Kamm // Am. J. Gastroenterol. - 2008. - 103 (4). - p. 1029-1035.

32. Otley, A. Budesonide for induction of remission in Crohn’s disease. / A.Otley, AH.Steinhart // Cochrane Database Syst. Rev. - 2005. - CD000296. - Review.

33. Papamichael, K. Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn’s disease: a prospective, two-year, single center, pilot study. / K.Papamichael, E.Archavlis, C.Lariou et al. // J. Crohns Colitis. - 2012. - 6 (9). - p. 924-931.

34. Peyrin-Biroulet, L. Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn’s disease: a meta-analysis. / L.Peyrin-Biroulet, P.Deltenre, S.Ardizzone et al. // Am. J. Gastroenterol. - 2009. - 104. - p. 2089-2096.

35. Peyrin-Biroulet, L. Surgery in a population-based cohort of Crohn’s disease from Olmsted County, Minnesota (1970-2004). / L.Peyrin-Biroulet, W.S.Harmsen, W.J.Tremaine et al. // Am. J. Gastroenterol. - 2012. - 107. - p. 1693-1701.

36. Reese, G.E. The effect of smoking after surgery for Crohn’s disease: a meta-analysis of observational studies. / G.E.Reese, T.Nanidis, C.Borysiewicz et al. // Int. J. Color Dis. - 2008. - 23 (12). - p. 1213-1221.

37. Regueiro, M. Infliximab prevents Crohn’s disease recurrence after ileal resection. / M.Regueiro, W.Schraut, L.Baidoo et al. // Gastroenterology. -2009. - 136 (2). - p. 441-450.

38. Regueiro, M. Infliximab Reduces Endoscopic, but not Clinical, Recurrence of Crohn’s Disease Following Ileocolonic Resection. / M.Regueiro, B.G.Feagan, B.Zou et al. // Gastroenterology. - 2016. - 150 (7).

39. Regueiro, M. Postoperative infliximab is not associated with an increase in adverse events in Crohn’s disease. / M.Regueiro, S.El-Hachem, K.E.Kip et al. // Dig. Dis. Sci. - 2011. - 56 (12). - p. 3610-3615.

40. Regueiro, M. Postoperative therapy with infliximab prevents long-term Crohn’s disease recurrence. / M.Regueiro, K.E.Kip, L.Baidoo et al. // Clin. Gastroenterol. Hepatol. - 2014. - 12. - p. 1494-502.

41. Rutgeerts, P. Controlled trial of metronidazole treatment for prevention of Crohn’s recurrence after ileal resection. / P.Rutgeerts, M.Hiele, K.Geboes et al. // Gastroenterology. - 1995. - 108. - Р. 1617-1621.

42. Rutgeerts, P. Ornidazole for prophylaxis of postoperative Crohn’s disease recurrence: a randomized, double-blind, placebo-controlled trial. / P.Rutgeerts et al. // Gastroenterology. - 2005. -128 (4). - p. 856-861.

43. Sakuraba, A. The use of infliximab in the prevention of postsurgical recurrence in polysurgeryCrohn’s disease patients: a pilot open-labeled prospective study. / A.Sakuraba, T.Sato, H.Matsukawa et al. // Int. J. Colorectal Dis. - 2012. - 27 (7) - p. 947-952.

44. Savarino, E. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn’s disease: a randomized controlled trial. / E.Savarino, G.Bodini, P.Dulbecco et al. // Am. J. Gastroenterol. - 2013. - 108 (11). - p. 1731-1742.

45. Savarino, E. Prevention of postoperative recurrence of Crohn’s disease by Adalimumab: a case series. / E.Savarino, P.Dulbecco, G.Bodini et al. // Eur. J. Gastroenterol. Hepatol. - 2012. - 24 (4). -p. 468-70.

46. Simillis, C. A meta-analysis comparing incidence of recurrence and indication for reoperation after surgery for perforating versus nonperforating Crohn’s disease. / C.Simillis, T.Yamamoto, G.E.Reese et al. // Am. J. Gastroenterol. - 2008. - 103 (1). - p. 196-205.

47. Sorrentino, D. Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn disease. / D.Sorrentino, G.Terrosu, C.Avellini et al. // Arch. Intern. Med. -2007. - 167 (16). - p. 1804-1807.

48. Sorrentino, D. Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn’s disease. / D.Sorrentino, A.Paviotti, G.Terrosu et al. // Clin. Gastroenterol. Hepatol. - 2010. - 8 (7). -p. 591-599.

49. Sorrentino, D. Prevention of postoperative recurrence of Crohn’s disease by infliximab. / D.Sorrentino, G.Terrosu, C.Avellini et al. // Eur. J. Gastroenterol. Hepatol. - 2006. - 18 (4). - p. 457-459.

50. Sorrentino, D. State-of-the-art medical prevention of postoperative recurrence of Crohn’s disease. / D.Sorrentino. // Nat. Rev. Gastroenterol. Hepatol. -2013. - 10 (7). - p. 413-422.

51. Steinhart, A.H. Corticosteroids for maintaining remission of Crohn’s disease. / A.H.Steinhart, K.Ewe, A.M.Griffiths et al. // Cochrane Database Syst. Rev. - 2003. - CD000301.

52. Terdiman, J.P. Prevention of postoperative recurrence in Crohn’s disease. / J.P.Terdiman. // Clin. Gastroenterol. Hepatol. - 2008. - 6 (6). - p. 616620.

53. Yamamoto, T. Factors affecting recurrence after surgery for Crohn’sdisease. / T.Yamamoto. // World. J. Gastroenterol. - 2005. - 11 (26). - p. 3971-3979.

54. Yamamoto, T. Strategies for 25. the prevention of postoperative recurrence of Crohn’s disease. / T.Yamamoto, T.Watanabe. // Colorectal Disease. - 2013. - 15 (12). - p. 1471-1480.